22 May 2013
Keywords: novo, nordisk, posts, strong, results, stroke, therapeutic
Article | 07 March 2005
Danish firm Novo Nordisk has posted encouraging results from a clinical trial of its NovoSeven (recombinant coagulation factor VIIa) in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 March 2005
28 February 2005
14 March 2005
© 2013 thepharmaletter.com